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Abstract 102 
Objective: To investigate systemic and ocular determinants of peripapillary retinal nerve 103 
fiber layer thickness (pRNFLT) in the European population. 104 
Design: Cross-sectional meta-analysis. 105 
Participants: 16,084 European adults from eight cohort studies (mean age range from 56.9 106 
± 12.3 to 82.1 ± 4.2 years) of the European Eye Epidemiology (E3) consortium. 107 
Methods: We examined associations with pRNFLT measured by spectral – domain optical 108 
coherence tomography in each study using multivariable linear regression and pooled results 109 
using random effects meta-analysis. 110 
Main Outcome Measures: Determinants of pRNFLT. 111 
Results:  Mean pRNFLT ranged from 86.8 ± 21.4 in the Rotterdam Study I to 104.7 ± 12.5 112 
µm in the Rotterdam Study III. We found the following factors to be associated with reduced 113 
pRNFLT: Older age (β=–0.38 m/year, 95% confidence interval (CI)=–0.57, –0.18), higher 114 
intraocular pressure (IOP; β= –0.36m/mmHg, 95% CI=–0.56, –0.15), visual impairment 115 
(β=–5.50m, 95% CI=–9.37, –1.64) and history of systemic hypertension (β=–0.54m, 95% 116 
CI=–1.01, –0.07) and stroke (β=–1.94m, 95% CI=–3.17, –0.72). A suggestive, albeit non-117 
significant, association was observed for dementia (β=–3.11m, 95% CI=–6.22, 0.01). Higher 118 
pRNFLT was associated with more hyperopic spherical equivalent (SE; β=1.39m/diopter, 119 
95% CI=1.19, 1.59) and smoking (β=1.53m, 95% CI=1.00, 2.06 for current smokers 120 
compared to never-smokers).  121 
Conclusions: In addition to previously described determinants such as age and refraction, 122 
we found that systemic vascular and neurovascular diseases were associated with reduced 123 
pRNFLT. These may be of clinical relevance, especially in glaucoma monitoring of patients 124 
with newly occurring vascular co-morbidities. 125 
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INTRODUCTION 126 
The assessment of peripapillary retinal nerve fiber layer thickness (pRNFLT) with Spectral – 127 
Domain Optical Coherence Tomography (SD-OCT) has become of increasing importance in 128 
the evaluation of glaucoma and its progression1,2. Although debated, pRNFLT measurements 129 
hold promise as a biomarker for neurodegenerative diseases such as Alzheimer’s disease 130 
(AD) and multiple sclerosis (MS)3,4. 131 
While pRNFLT measurements have increased insight into the development of diseases, it 132 
has been difficult to evaluate which changes fall within the physiological range. Most OCT 133 
devices compare pRNFLT measurements against reference databases that are built into the 134 
machine analysis software. These data are mostly derived from relatively small sample 135 
populations. Whether these databases adequately capture normal anatomical variation 136 
across a wide age range remains unclear.  137 
Only few studies investigated ocular and systemic determinants of pRNFLT in the general 138 
population5. They reported inconsistent results for many ocular and systemic parameters 139 
including sex or body-mass-index (BMI)5,6. To date, only age7,8, refraction9 or axial length 140 
(AL)10 have been consistently associated with measured pRNFLT across studies. In addition, 141 
the majority of large-scale studies assessing these associations were performed in (young) 142 
Asian populations6,11–14. It is unclear whether or not these results can be applied to 143 
European, i.e. mostly Caucasian, populations.  144 
The purpose of this study was to assess systemic and ocular determinants of pRNFLT using 145 
pooled data from eight European population-based studies. 146 
 147 
METHODS 148 
Included studies 149 
The European Eye Epidemiology (E3) consortium is a collaborative network of population-150 
based studies across Europe with the overarching aim of developing and analyzing large 151 
pooled datasets to increase understanding of eye disease and vision loss15. For this study, 152 
we analyzed data on pRNFLT from eight different studies. The included data were cross-153 
Mauschitz et al., Systemic and ocular determinants of peripapillary retinal nerve fiber layer thickness 
measurements in the E3 population 
 
6 
 
sectional and the right eye was chosen to be the study eye. All studies adhered to the tenets 154 
of the Declaration of Helsinki and had local ethical committee approval. All participants gave 155 
written informed consent. 156 
 157 
Assessments and data analyses 158 
Retinal nerve fiber layer thickness was measured as global pRNFLT with different OCT 159 
devices, scan modalities (mostly circular scans) and automated segmentation algorithms in 160 
the respective studies (see Table 1). pRNFLT outliers were excluded prior to analyses 161 
according to Chauvenet’s criterion. Briefly, depending on sample size we excluded 162 
participants with pRNFLT above or below a certain range of standard deviations from the 163 
mean16. To investigate determinants of pRNFLT, multivariable linear regression models 164 
including the variables of interest were conducted. Factors to be tested for association with 165 
pRNFLT were considered in multiple steps. As first and most important step, variables were 166 
chosen a priori based on literature and availability in the individual studies. Subsequently, we 167 
performed univariable linear regression models of potential factors at study level to assess 168 
possible impact on pRNFLT. In the last step the factors of the multivariable models were 169 
decided on as a trade-off between priority of the respective factors and the maximum 170 
possible population size of the model.  171 
The independent variables of the multivariable linear regression model were age, sex, body-172 
mass-index (BMI), visual impairment as defined by the World Health Organization (WHO) 173 
(best corrected visual acuity (BCVA) <0.3 decimal), intraocular pressure (IOP), spherical 174 
equivalent (SE), smoking status and history of systemic hypertension, diabetes, stroke and 175 
dementia. The multivariable regression model was conducted for each individual study and 176 
residuals were then plotted and normal distribution assessed. Since OCT devices were 177 
changed within the course of the Rotterdam Study (From 3D-OCT 1000 to 3D-OCT 2000, 178 
Topcon Medical Systems, Oakland, NJ, USA), we controlled for the OCT device in the 179 
multivariable regression models of the Rotterdam Study II and III. In the TwinsUK Study, we 180 
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performed a hierarchical multivariable regression model to control for family dependencies 181 
between twins. 182 
Subsequently, random-effects meta-analysis was used to combine effect estimates (beta 183 
coefficients) of each individual predictor from the multivariable regression model among 184 
studies. A random-effects approach was chosen a priori based on the heterogeneity in the 185 
data caused by the different OCT devices17 and the set-up of the studies. Our analyses were 186 
conducted twice, with and without known glaucoma patients. 187 
Not all independent variables of the multivariable regression model were available in every 188 
participating study. The multivariable regression models in the respective studies were 189 
therefore performed without the missing variables and the study was excluded from the 190 
meta-analysis of that respective missing covariate. All analyses were performed with the 191 
statistical software RStudio (R version 3.4.1, RStudio Inc., Boston, MA, 192 
https://www.rstudio.com/), statistical significance was set at p < 0.05.  193 
 194 
RESULTS 195 
A total of 16,084 participants from eight population-based studies were included, about one 196 
percent pRNFLT outliers per study were excluded (supplemental Table 1b). The mean age of 197 
participants ranged from 56.9 ± 12.3 years in the LIFE Study to 82.1 ± 4.2 years in the 198 
Alienor Study. Mean global pRNFLT ranged from 86.8 ± 21.4 microns in the Rotterdam Study 199 
I to 104.7 ± 12.5 microns in the Rotterdam Study III (Table 1). Further participant 200 
characteristics for each study are presented in supplemental Table 1b. The results of the 201 
multivariable regression models for each individual study are reported in Table 2. Data on 202 
dementia were only available in the Rotterdam Study cohorts and the Alienor Study. 203 
Furthermore, in the TwinsUK Study no sufficient data were available on visual impairment, 204 
glaucoma, hypertension and smoking status; in the LIFE Study, no data were available on 205 
visual impairment, SE and IOP. 206 
In the meta-analyzed multivariable regression model (Table 3 and Figures 1a and 1b), age 207 
and IOP were negatively associated with pRNFLT, even after excluding glaucoma patients. A 208 
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history of stroke and hypertension were both associated with a reduced pRNFLT. When 209 
substituting hypertension with mean systolic blood pressure (in mmHg), no association was 210 
found. 211 
A suggestive, but non-significant association with reduced pRNFLT was observed for 212 
dementia. Visual impairment as defined by the WHO was associated with reduced pRNFLT 213 
in the meta-analysis. We found this association in the Alienor and Rotterdam Study I-III, 214 
while there was no association in the Montrachet and Coimbra Study. 215 
Women had a thicker pRNFLT than men in the meta-analysis. However, when correcting for 216 
AL rather than SE in the five studies with data on AL, this association disappeared. SE was 217 
positively associated with pRNFLT, even after excluding highly myopic (< -6 diopters) and 218 
highly hyperopic eyes (> +4 diopters) as well as eyes with pseudophakia (supplemental 219 
Figures A and B). Longer AL was associated with reduced pRNFLT in our sensitivity 220 
analyses (beta=–3.48m per mm longer AL, 95% CI=–4.18, –2.77) (supplemental Figure C). 221 
Both, former and current smoking were associated with thicker pRNFLT, but prevalence and 222 
associations differed considerably between studies. To assess the influence of education on 223 
smoking, we corrected for education and the associations persisted. After excluding data 224 
from the LIFE Study, which is the largest study with the highest proportion of smokers (data 225 
weighted >60% in the meta-analysis), the association remained significant for current but not 226 
for former smoking (supplemental Figures D-G). For BMI, we found a small but significant 227 
association with increased pRNFLT after excluding glaucoma patients. All associations 228 
except for former smoking held true after excluding the 619 known glaucoma patients (Table 229 
3). Furthermore, we detected no relevant changes of associations when performing the 230 
multivariable regression analyses stratified by sex or when excluding the LIFE study cohort 231 
being the largest single study (results not reported).  232 
 233 
DISCUSSION 234 
Our study confirms the previously reported associations of age and SE with pRNFLT and 235 
identifies several additional factors associated with pRNFLT, namely IOP (even in individuals 236 
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without a history of glaucoma), stroke, hypertension and smoking. Furthermore, we found a 237 
trend of reduced pRNFLT in participants with dementia. Our results suggest that a number of 238 
ocular as well as systemic factors need to be considered when assessing pRNFLT. To date, 239 
none of this has for example been implemented as potentially influencing factors in reference 240 
databases for OCT devices or any algorithms assessing pRNFLT change.  241 
First publications on determinants of OCT – based pRNFLT measurements reported older 242 
age and greater AL to be associated with thinner pRNFLT18,19. Budenz and coworkers 243 
investigated determinants of pRNFLT in 328 normal subjects aged 18 to 85 years using time 244 
domain – optical coherence tomography (TD–OCT) and described a decrease of 2.0 microns 245 
pRNFLT per decade and a decrease of 2.2 microns per millimeter AL19. These estimates are 246 
smaller but still compare to our results (decrease of 3.8 microns pRNFLT on average per 247 
decade and 3.48 microns per millimeter AL). A subsequent study evaluated determinants of 248 
pRNFLT in 542 healthy adults aged 40 to 80 years using SD – OCT (Cirrus HD-OCT; Carl 249 
Zeiss Meditec, Inc., Dublin, CA) and confirmed the associations of pRNFLT with age and 250 
AL11. 251 
Subsequently, larger population studies mostly from Asia were conducted to investigate 252 
further determinants of pRNFLT. We have affirmed results from the Beijing Eye Study in 253 
2548 participants considering the influence of age and refractive error. That study also 254 
showed a higher pRNFLT of 2.9 microns in women14, in keeping with our results of women 255 
having a higher pRNFLT of 2.2 microns. Similar to our models, the Beijing Eye Study 256 
corrected for refractive error instead of actual AL. Interestingly, after correcting for AL in our 257 
analyses, sex was no longer associated with pRNFLT. Based on this, we hypothesize that 258 
AL, which is on average shorter in women, confounds the effect of sex on pRNFLT. In 259 
general, SE is a good proxy for AL and we found a strong association of higher SE with 260 
thicker pRNFLT, even in both our sensitivity analyses, which eliminated subjects with high 261 
refractive errors. The underlying mechanisms of the association of longer AL and thinner 262 
pRNFLT are arguable20. Frequently suggested mechanisms are either a stretching due to a 263 
longer eye bulb or artificially decreased measurements due to magnification21,22. However, 264 
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irrespective of the causal mechanism, the clinical relevance of adjusting for refraction or AL 265 
in OCT – imaging seems obvious.  266 
Higher IOP was associated with reduced pRNFLT in our analyses even after excluding 267 
known glaucoma patients. However, since glaucoma was self-reported in some of the 268 
participating studies, not all actual glaucoma patients might have been excluded in our 269 
analyses. Visual impairment (BCVA < 0.3 decimal) as a proxy for any ocular pathology was 270 
associated with thinner pRNFLT in the Alienor Study and all of the Rotterdam Studies. The 271 
Coimbra and Montrachet Study were likely underpowered to find an effect, because of very 272 
few cases with reduced BCVA in these studies. 273 
Previous studies reported contradictory results on the impact of hypertension and blood 274 
pressure on pRNFLT9,23,24. Our results show reduced pRNFLT in hypertensive patients, but 275 
no association of pRNFLT with actual systolic blood pressure. Blood pressure 276 
measurements, however, are known to vary with method and associations with systolic blood 277 
pressure may have been masked by any use of antihypertensive medication. In contrast to 278 
hypertension, most studies investigating the effect of diabetes on pRNFLT report diabetic 279 
patients to have thinner pRNFLT25,26. This is in not agreement with our results that do not 280 
show an association of reduced pRNFLT in diabetic patients. Nether the less, we 281 
hypothesize that microvascular pathology and ischemia due to hypertension and/or diabetes 282 
may be a cause for reduced pRNFLT, as it has been suggested previously25. 283 
Both, former and current smoking were associated with thicker pRNFLT in our meta-analysis, 284 
even in several sensitivity analyses including correction for educational level. This 285 
association does not seem biologically plausible given the observed pRNFLT decrease in 286 
metabolic diseases. Potential biologic explanations could be reduced axonal flow or axonal 287 
swelling in the course of axonal degeneration due to intake of neurotoxins and cytotoxins 288 
from cigarette smoke. However, our results are in contrast with findings of earlier studies27,28, 289 
which reported reduced pRNFLT in smokers. Suggested mechanisms leading to decreased 290 
pRNFLT were toxic damage through free radicals, increased IOP and reduced perfusion27–29. 291 
We controlled for IOP as well as hypertension and diabetes, which all may influence 292 
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perfusion. It is therefore unclear what might explain this association. Current smokers were 293 
on average younger in our participating studies compared to never and former smokers. 294 
Hence, even though we controlled for age in our models, we cannot entirely rule out residual 295 
confounding. Additionally, the E3 studies are not representative studies of European 296 
populations and smoking percentages therefore do not reflect actual percentages. There was 297 
heterogeneity between studies considering smoking prevalence and oppositional effects of 298 
former smoking in some studies. After excluding the LIFE Study, which was dominantly 299 
weighted in the smoking meta-analysis, the Rotterdam Study III showed to be weighted 300 
strongest for current smoking. When excluding also the Rotterdam Study III, the impact of 301 
smoking is weakened but holds true. Still, the associations seem to be particularly driven by 302 
the large studies. This is also underlined by increasing heterogeneity for former and current 303 
smoking in the meta-analysis after excluding the LIFE Study. Moreover, there is no 304 
information on the time interval between cessation of smoking and OCT – imaging for the 305 
former smokers, which may have an impact, as well. Further studies are needed to confirm 306 
or refute our observation, which may well be a chance finding. 307 
Past studies have reported stroke patients to have thinner pRNFLT, which was hypothesized 308 
to be caused by transneuronal retrograde degeneration30,31. Our data confirm the association 309 
of stroke and decreased pRNFLT. Additionally, in dementia patients we found a trend of 310 
reduced pRNFLT. Again, this is in accordance to various previous studies, which report 311 
dementia patients to have reduced pRNFLT4,32. Thus far, the underlying mechanisms remain 312 
unclear. Loss of peripapillary RNFL is a hallmark of glaucoma and longitudinal pRNFLT 313 
evaluation is a crucial part of glaucoma management. In our meta-analysis, all associations 314 
persisted after excluding known glaucoma patients except for former smoking. This indicates 315 
that the detected determinants are independent of the presence of glaucoma. 316 
As described previously, structural decline of pRNFLT occurs before functional loss in 317 
perimetry in glaucoma patients. An earlier study reported the difference in pRNFLT between 318 
glaucomatous and healthy eyes eight years before the onset of visual field impairment to be 319 
around 5 µm33. This is in the range of some associations found in our study and underlines 320 
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the potential impact on the interpretation of pRNFLT. Our results have two main clinical 321 
implications. Firstly, the normative databases built into the devices should reflect our results, 322 
when presenting normal values for pRNFLT. Also, presence of vascular disease including a 323 
history of stroke should be considered when defining normative datasets or when clinically 324 
evaluating pRNFLT. As discussed above, the magnitude of impact of the respective 325 
determinants may have clinical relevance, especially in the presence of more than one factor 326 
reducing pRNFLT. Secondly, in glaucoma or other patients followed up with pRNFLT 327 
measurements, an incident stroke or dementia may cause a decrease in pRNFLT, which 328 
would not primarily be due to glaucoma or other ocular disease progression. For example, 329 
this may simulate an aggravation of glaucoma and needs to be considered by the clinician 330 
when tailoring the glaucoma management. 331 
The strengths of this study consist of the large pooled sample combining data of eight 332 
studies from five European countries. To our knowledge, this study represents the largest 333 
European study on determinants of pRNFLT thus far. As mentioned, previous population 334 
studies reporting data on associations with pRNFLT were conducted in mostly Asian 335 
populations and results cannot directly be transferred to European individuals. The 336 
associations of this study were assessed in meta-analyses of all participating populations, 337 
thus they are not limited to one single population only. This reduces the possibility that an 338 
association was solely due to chance within one population and increases generalizability. 339 
However, several limitations of our study need to be considered. The use of different OCT–340 
devices between studies may have increased variability and prohibited direct pooling of 341 
pRNFLT data. To overcome this lack of direct comparability we performed the analysis 342 
separately within studies and then pooled studies’ effect estimates using random-effect 343 
meta-analysis. Furthermore, we found no interactions between type of device and any 344 
predictor variable in additional sensitivity analyses in the Rotterdam Study II and III, which 345 
had a device upgrade within course of the study. However, residual influence of different 346 
OCT devices cannot be entirely excluded. As expected when combining different large- scale 347 
population studies, we observed between study heterogeneity for the independent variables 348 
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and their influence on pRNFLT. The degree of heterogeneity of the respective covariates 349 
was assessed using the I2 – statistics and ranged from 0% to 97% (see Table 3). As 350 
described, this heterogeneity between studies was addressed by using random effect meta-351 
analysis17. In accordance with previous literature, the relationship between pRNFLT and age 352 
was linear in our sample. Having no data for children and young adults, we do not know 353 
whether the relationship between pRNFLT and age is strictly linear throughout life but would 354 
assume so based on our data. Thus, we investigated associations using multivariable linear 355 
regression modeling. Based on this, any non-linear relationships may have been 356 
underrepresented. Quality control was performed within each study differently (supplemental 357 
Table 2). Some studies performed manual (re)-segmentation, excluded OCT images below a 358 
certain scan quality and scans with artifacts, while others included all scans with sufficient 359 
quality as evaluated by the performing technician. As sensitivity analysis we excluded 360 
participants with an image quality value below 45 (as recommended by the manufacturer) in 361 
the Rotterdam Studies I-III. We found no relevant changes of direction in any association, but 362 
the confidence intervals became broader due to a reduced sample size (supplemental Table 363 
3). Hence, even though the lack of centralized quality control is a limitation to our analyses, 364 
the impact of poor quality scans seems to be low as indicated by our supplemental sensitivity 365 
analyses. Within each study, the number of participants in which OCT imaging could not be 366 
performed or in which the images were of low quality and thus unusable is a small proportion 367 
only (supplemental Table 2). For example, in the Rotterdam Study I-III the number of 368 
participants with no or insufficient OCT data was 10%, 6% and 15%, respectively. These 369 
subjects were older and more likely to have stroke (RS I), dementia (RS II and III) and 370 
hypertension (RS III) than the included participants. This indicates that our associations may 371 
be underestimations of the true effect. Several independent variables were not available in 372 
some studies. Therefore not all multivariable models could be corrected for all variables. 373 
However, no relevant differences of associations were detectable, when comparing studies 374 
with and studies without any missing data. Hence, the absence of certain variables in some 375 
studies did not relevantly alter the associations of the available data. Methods of 376 
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assessments varied between our studies. This concerns e.g. the best-corrected visual acuity, 377 
which was sometimes measured subjectively and sometimes by autorefractor. In addition, 378 
information on diseases was assessed differently. While glaucoma was defined based on 379 
optic disc evaluation and perimetry in the Alienor Study and Rotterdam Study I-III, it was self-380 
reported in the LIFE Study. Furthermore, we did not distinguish between the various types of 381 
dementia, which may have different impact on pRNFLT. These differences contribute again 382 
to larger heterogeneity and the relation between self-reported diseases and pRNFLT may 383 
have been estimated with less precision. Lastly, our data were cross-sectional only, thus 384 
causal deductions from the detected associations are limited and further longitudinal studies 385 
are needed. 386 
In conclusion, the current analyses identified important additional determinants of pRNFLT, 387 
which should be considered when assessing pRNFLT both clinically and in epidemiological 388 
research. The magnitude of changes in pRNFLT by determinant is likely clinically relevant 389 
and the biology of pRNFLT thinning is complex, with mechanical pressure, microvascular 390 
ischemia and neuronal degeneration being implied. This is reflected in the complexity of 391 
factors, which influence pRNFLT and hence need to be considered. In particular, the 392 
associations with systemic vascular and neurovascular diseases merit further research. 393 
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Figure legends 
 
Figure 1a: Forest plots of meta-analyzed associations with pRNFLT from multivariable 
regression models (Age, sex, spherical equivalent, intraocular pressure and visual 
impairment). The beta-coefficients [95% Confidence Interval] show the influence of each 
parameter on pRNFLT within the respective study, the percentage represents the 
mathematically determined weighting of each study within the meta-analysis. 
 
Figure 1b: Forest plots of meta-analyzed associations with pRNFLT from multivariable 
regression models (Smoking, hypertension, stroke and dementia). The beta-coefficients 
[95% Confidence Interval] show the influence of each parameter on pRNFLT within the 
respective study, the percentage represents the mathematically determined weighting of 
each study within the meta-analysis. 
Table 1. Descriptive data for participating studies 
Study Years City/country 
pRNFLT measurements 
N 
Women 
(%) 
Mean age in 
years ± SD 
Mean global pRNFLT in 
microns ± SD OCT - Device Details 
Alienor Study 2009-2011 Bordeaux, France 
Spectralis OCT, 
Heidelberg Engineering 
 
12° / 3.4mm diameter 
ring scan on ONH 
529 62% 82.1±4.2 89.2±16.0 
Coimbra Eye Study 2016-2017 Coimbra, Portugal 618 54% 71.8±6.2 96.8±12.0 
Montrachet Study 2009-2013 Dijon, France 803 60% 82.0±3.7 90.3±13.7 
LIFE Study 2011-2014 Leipzig, Germany 8351 52% 56.9±12.3 97.4±10.6 
Rotterdam Study I 2009-2011 
Rotterdam, 
the Netherlands 
 
3D OCT 1000, 
Topcon Medical Systems 
6.0 x 6.0mm on ONH 
 
1287 57% 79.3±4.6 86.8±21.4 
Rotterdam Study II 2011-2012 3D OCT 1000 and 2000, 
Topcon Medical Systems 
1376 55% 72.4±4.9 98.2±17.2 
Rotterdam Study III 2012-2013 2267 56% 62.2±5.6 104.7±12.5 
Twins UK Study 2014-2016 UK (multiple cities) 
iVue, 
Optovue 
3.45 mm diameter ring 
scan on ONH 
853 98% 61.8±12.2 96.4±9.8 
pRNFLT=Peripapillary retinal nerve fiber layer thickness, SD=Standard deviation, OCT=Optical coherence tomography, ONH=Optic nerve head 
 
 
Table 2a. Associations with peripapillary retinal nerve fiber layer thickness (pRNFLT) for each individual study 
 Alienor (n=529)  Coimbra (n=618)  Montrachet (n=803)  LIFE (n=8351)  
 β (95% CI) p  β (95% CI) p  β (95% CI) p  β (95% CI) p  
             
Age  
(per year) 
-0.22 
(-0.55; 0.11) 
0.12  
-0.09 
(-0.24; 0.07) 
0.28  
-0.37 
(-0.62; -0.12) 
0.004  
-0.10 
(-0.12; -0.08) 
<0.001  
Female sex 
3.98 
(0.84; 7.11) 
0.01  
2.78 
(0.70; 4.85) 
0.01  
3.85 
(1.78; 5.92) 
<0.001  
1.36 
(0.90; 1.82) 
<0.001  
BMI  
(per kg/m2) 
0.13 
(-0.22; 0.48) 
0.46  
-0.10 
(-0.30; 0.11) 
0.37  
0.33 
(0.09; 0.57) 
0.006  
0.08 
(0.03; 0.13) 
0.002  
SE 
(per diopter) 
1.22 
(0.50; 1.94) 
<0.001  
1.15 
(0.60; 1.69) 
<0.001  
1.88 
(1.44; 2.31) 
<0.001  N/A N/A  
IOP 
(per mmHg) 
-0.71 
(-1.32; -0.10) 
0.02  
-0.52 
(-0.84; -0.19) 
0.002  
-0.31 
(-0.60; -0.03) 
0.03  N/A N/A  
Visual 
impairment* 
-6.42 
(-12.47; -0.37) 
0.04  
-0.15 
(-4.64; 4.34) 
0.95  
-0.49 
(-4.46; 3.48) 
0.81  N/A N/A  
Former 
smoker 
-0.47 
(-3.74; 2.81) 
0.78  
-0.57 
(-3.67; 2.53) 
0.72  
2.39 
(0.25; 4.53) 
0.03  
0.60 
(0.06; 1.14) 
0.03  
Current 
smoker 
1.48 
(-4.99; 7.96) 
0.65  
1.51 
(-5.74; 8.77) 
0.68  
1.58 
(-4.33; 7.48) 
0.60  
1.43 
(0.85; 2.02) 
<0.001  
Hypertension 
1.33 
(-1.40; 4.05) 
0.34  
-1.08 
(-3.07; 0.91) 
0.29  
-0.62 
(-2.55; 1.32) 
0.53  
-0.46 
(-0.98; 0.07) 
0.09  
Diabetes 
2.11 
(-2.30; 6.52) 
0.35  
1.34 
(-0.88; 3.55) 
0.24  
-2.08 
(-5.29; 1.13) 
0.21  
-1.25 
(-2.03; -0.46) 
0.002  
Stroke 
-3.53 
(-14.05; 6.99) 
0.51  
-2.85 
(-7.60; 1.91) 
0.24  
0.02 
(-5.20; 5.25) 
0.99  
-2.96 
(4.56; -1.36) 
<0.001  
Dementia 
-5.11 
(-12.06; 1.84) 
0.15  N/A N/A  N/A N/A  N/A N/A  
Results from the multivariable regression models; N/A= not available 
*Visual impairment as defined by the World Health Organization (<0.3 decimal BCVA); BMI=Body Mass Index, SE=Spherical equivalent, IOP=Intraocular 
pressure 
  
Table 2b. Associations with peripapillary retinal nerve fiber layer thickness (pRNFLT) for each individual study (continued) 
 Rotterdam 1 (n=1287)  Rotterdam 2 (n=1376)  Rotterdam 3 (n=2267)  Twins UK (n=853)  
 β (95% CI) p  β (95% CI) p  β (95% CI) p  β (95% CI) p  
             
Age  
(per year) 
-0.61 
(-0.87; -0.36) 
<0.001  
-0.91 
(-1.08; -0.73) 
<0.001  
-0.50 
(-0.59; -0.41) 
<0.001  
-0.24 
(-0.29; -0.18) 
<0.001  
Female sex 
3.70 
(1.23; 6.16) 
0.003  
1.36 
(-0.31; 3.03) 
0.11  
0.49 
(-0.50; 1.48) 
0.33  
3.58 
(-1.01; 8.16) 
0.13  
BMI  
(per kg/m2) 
0.11 
(-0.18; 0.40) 
0.46  
0.00 
(-0.002; 0.002) 
1.00  
0.12 
(0.00; 0.24) 
0.05  
-0.07 
(-0.19; 0.05) 
0.27  
SE 
(per diopter) 
1.09 
(0.58; 1.60) 
<0.001  
1.67 
(1.32; 2.02) 
<0.001  
1.29 
(1.10; 1.49) 
<0.001  
1.28 
(1.02; 1.55) 
<0.001  
IOP 
(per mmHg) 
-0.49 
(-0.84; -0.14) 
0.005  
-0.65 
(-0.91; -0.39) 
<0.001  
-0.05 
(-0.23; 0.12) 
0.56  
-0.05 
(-0.26; 0.16) 
0.62  
Visual 
impairment* 
-11.27 
(-17.93; -4.61) 
<0.001  
-7.68 
(-13.80; -1.55) 
0.01  
-9.56 
(-14.87; -4.24) 
<0.001  N/A N/A  
Former 
smoker 
2.60 
(-0.05; 5.25) 
0.06  
0.87 
(-0.95; 2.68) 
0.36  
-0.13 
(-1.20; 0.95) 
0.82  N/A N/A  
Current 
smoker 
2.96 
(-1.48; 7.40) 
0.19  
3.86 
(0.94; 6.78) 
0.009  
1.34 
(-0.18; 2.87) 
0.08  N/A N/A  
Hypertension 
2.08 
(-1.71; 5.86) 
0.28  
0.46 
(-1.86; 2.77) 
0.70  
-1.37 
(-2.43; -0.31) 
0.01  N/A N/A  
Diabetes 
-0.54 
(-3.45; 2.36) 
0.71  
-1.72 
(-3.92; 0.48) 
0.12  
0.40 
(-1.30; 2.10) 
0.65  
-4.29 
(-8.34; -0.24) 
0.04  
Stroke 
1.25 
(-2.83; 5.32) 
0.55  
-2.06 
(-5.67; 1.55) 
0.26  
-1.22 
(-4.19; 1.76) 
0.42  
-1.51 
(-5.49; 2.48) 
0.46  
Dementia 
-4.17 
(-8.82; 0.48) 
0.08  
-0.55 
(-5.96; 4.86) 
0.84  
-1.27 
(-24.41; 21.86) 
0.91  N/A N/A  
Results from the multivariable regression models; N/A= not available 
*Visual impairment as defined by the World Health Organization (<0.3 decimal BCVA); BMI=Body Mass Index, SE=Spherical equivalent, IOP=Intraocular pressure 
Table 3. Meta-analyzed associations with peripapillary retinal nerve fiber layer thickness (pRNFLT) 
 All participants    Excluding known glaucoma      
 β (95% CI) p I
2 
 β (95% CI) p I
2 
  
Age 
(per year) 
-0.38 
(-0.57; -0.18) 
<0.001 97% 
 -0.35 
(-0.60; -0.10) 
0.006 97% 
  
Female sex 
2.17 
(1.15; 3.20) 
<0.001 69% 
 1.79 
(0.93; 2.65) 
<0.001 59% 
  
BMI 
(per kg/m
2
) 
0.06 
(-0.02; 0.14) 
0.15 54% 
 0.09 
(0.00; 0.18) 
0.05 53% 
  
SE 
(per diopter) 
1.39 
(1.19; 1.59) 
<0.001 49% 
 1.36 
(1.16; 1.57) 
<0.001 40% 
  
IOP 
(per mmHg) 
-0.36 
(-0.56; -0.15) 
<0.001 74% 
 -0.42 
(-0.65; -0.20) 
<0.001 71% 
  
Visual impairment
*
 
-5.50 
(-9.37; -1.64) 
0.005 69% 
 -4.75 
(-9.12; -0.38) 
0.03 77% 
  
Former smoker 
0.58 
(0.14; 1.02) 
0.009 0% 
 0.79 
(-0.01; 1.60) 
0.05 43% 
  
Current smoker 
1.53 
(1.00; 2.06) 
<0.001 0% 
 1.49 
(0.97; 2.02) 
<0.001 0% 
  
Hypertension 
-0.54 
(-1.01; -0.07) 
0.03 4% 
 -0.62 
(-1.11; -0.13) 
0.01 7% 
  
Diabetes 
-0.69 
(-1.69; 0.31) 
0.18 40% 
 -0.33 
(-1.32; 0.67) 
0.52 40% 
  
Stroke 
-1.94 
(-3.17; -0.72) 
0.002 7% 
 -2.06 
(-3.27; -0.84) 
<0.001 2% 
  
Dementia 
-3.11 
(-6.22; 0.01) 
0.05 0% 
 -2.66 
(-5.86; 0.55) 
0.10 0% 
  
All participants – results of the meta analysis of the multivariable regression models including all participants (n=16084) 
Excluding known glaucoma – results of the meta analysis of the multivariable regression models excluding the 619 known glaucoma patients (n= 
14695, without TwinsUK Study data, since no data on glaucoma were available); I
2
=Heterogeneity of covariate in the meta-analysis; *Visual 
impairment as defined by the World Health Organization (<0.3 decimal BCVA); BMI=Body Mass Index, SE=Spherical equivalent, IOP=Intraocular 
 pressure 
